Investigational heptavalent botulinum antitoxin (HBAT) is now the primary antitoxin for US noninfant botulism patients. HBAT consists of equine Fab/F(ab')2 IgG fragments, which are cleared from circulation faster than whole immunoglobulins. Rebound botulism after antitoxin administration is not previously documented but occurred in our patient 10 days after HBAT administration. © 2011 The Author.
CITATION STYLE
Fagan, R. P., Neil, K. P., Sasich, R., Luquez, C., Asaad, H., Maslanka, S., & Khalil, W. (2011). Initial recovery and rebound of type F intestinal colonization botulism after administration of investigational heptavalent botulinum antitoxin. Clinical Infectious Diseases, 53(9). https://doi.org/10.1093/cid/cir550
Mendeley helps you to discover research relevant for your work.